Previous Article | Next Article ![]()
Infection and Immunity, October 1999, p. 5206-5214, Vol. 67, No. 10
Department of Microbiology and Molecular
Genetics, University of Vermont,1 and
Vermont Cancer Center,2 Burlington,
Vermont 05405
Received 27 April 1999/Returned for modification 14 June
1999/Accepted 16 July 1999
Studies in our laboratory have identified two fimbria-associated
adhesins, FimA and Fap1, of Streptococcus parasanguis
FW213. In this study, we isolated and sequenced DNA fragments linked to
fimA to determine if they contained additional factors
associated with adherence, virulence, or survival in the host. An open
reading frame just upstream and divergently transcribed from the
fimA operon was identified and named pepO.
Northern hybridization indicated that pepO is transcribed
as a monocistronic message. pepO encodes a predicted
631-amino-acid protein with a molecular mass of approximately 70.6 kDa.
PepO contains the essential motif HEXXH, typical of many zinc-dependent
metalloproteases and metallopeptidases. PepO has significant sequence
identity to mammalian metallopeptidases, including
endothelin-converting enzyme, which converts a potent vasoconstrictor
into its active form, and neutral endopeptidase (NEP), which is
involved in terminating the activity of opioid peptides. The opioid
peptide metenkephalin is a natural substrate of NEP. Cell extracts of
FW213 cleaved metenkephalin at the same site as does NEP, while an
extract from an insertionally inactivated pepO mutant did
not. These results indicate that FW213 pepO encodes an
enzyme with activity similar to that of known mammalian endopeptidases. Phylogenetic analysis of PepO and its homologues suggests lateral genetic exchange between bacteria and eukaryotes.
Members of the sanguis group of
streptococci are highly successful colonizers of both hard and soft
surfaces in the human oral cavity and thus represent a significant
portion of the indigenous microflora (24). Members of this
group of bacteria are important in the development of oral diseases
because they are the primary colonizers of newly erupted or freshly
cleaned tooth surfaces (7, 35). This colonization initiates
the formation of dental plaque, the biofilm associated with caries and
periodontal disease. In addition, these organisms are major etiological
agents of subacute bacterial endocarditis (5). The
successful establishment of streptococci in the host appears to be
dependent on the ability of these organisms to adhere to oral as well
as to other host surfaces. These surfaces include epithelia, salivary
pellicle, platelets, other bacteria in plaque, and extracellular matrix components, particularly fibronectin (22, 28). Adherence is facilitated by multiple adhesins expressed on the surface of the bacterial cell (27, 28).
Adhesion of the oral bacterium Streptococcus parasanguis
FW213 to an in vitro tooth surface model, saliva-coated hydroxyapatite (SHA), is mediated by peritrichous surface fimbriae (15, 21, 22). The genes encoding two fimbria-associated adhesins, Fap1 and
FimA, in FW213 have been identified. The fap1 gene encodes a
high-molecular-weight glycoprotein that is important for adhesion to
SHA and appears to be involved in the assembly of fimbriae (56). The fimA gene encodes a 36-kDa lipoprotein
(20, 23) that is an important virulence factor in S. parasanguis endocarditis and appears to promote adherence to
fibrin in cardiac vegetations (6). fimA is part
of an operon that encodes components of an ATP-binding cassette-type
membrane transport system. In addition to fimA, the
fim locus includes fimB (formerly
orf1), which encodes an ATP-binding protein, and
fimC (formerly orf5), which encodes a hydrophobic
transmembrane protein (20). Homologues of FimA have been
identified, and sequence analysis of FimA and its homologues has
suggested that this group of proteins belongs to a new subfamily of
solute-binding proteins that potentially bind metals (13, 29). Just downstream of the fimA operon is the gene
tpx (formerly orf3), which encodes a 20-kDa
protein (20) with significant homology to a periplasmic
thiol peroxidase (Tpx) of Escherichia coli (8).
In E. coli, Tpx is an enzyme that prevents the formation of
reactive oxygen species toxic for many bacteria. Recently, it has been
shown that S. parasanguis Tpx functions in a similar manner
(54). Tpx may play a role of particular importance in the
survival of bacteria, such as S. parasanguis, that lack catalase.
In this study, we isolated and sequenced DNA fragments upstream of the
fimA operon in order to identify additional factors that may
be associated with adherence to host surfaces, virulence, or survival
in the host environment. We identified an open reading frame (ORF) that
is divergently transcribed from the fimA operon and that
encodes an endopeptidase (PepO) with high sequence identity to known
bacterial and mammalian endopeptidases.
Bacterial strains, plasmids, and media.
The bacterial
strains and plasmids used in this study are listed in Table
1. The wild-type S. parasanguis (formerly S. sanguis) strain used was FW213
(11). Strain VT1346
pepO::Kmr was constructed by
insertional inactivation of pepO as described below.
Streptococcal strains were grown statically in Todd-Hewitt (TH) broth
(Difco Laboratories, Detroit, Mich.) in the presence of 5%
CO2 at 37°C. Tetracycline (15 µg/ml) or kanamycin (120 µg/ml) was added as required. E. coli JM109 (Promega,
Madison, Wis.) served as the host for cloning experiments and for
plasmid propagation. Strain LE392 (Promega) served as the host strain
for the propagation of recombinant bacteriophage. E. coli
was grown in Luria-Bertani medium or NZYM medium (40) and,
when required for plasmid selection, ampicillin (100 µg/ml),
tetracycline (15 µg/ml), or kanamycin (25 µg/ml) was included. Agar
was added to a final concentration of 1.5% to prepare solid medium.
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Streptococcus parasanguis pepO Encodes
an Endopeptidase with Structure and Activity Similar to Those of
Enzymes That Modulate Peptide Receptor Signaling in Eukaryotic
Cells
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
TABLE 1.
Bacterial strains and plasmids used in this study
|
DNA manipulations.
Molecular biology techniques were carried
out essentially as described previously (40). Plasmids were
isolated from E. coli with Mini or Midi column plasmid
purification kits (Qiagen, Valencia, Calif.). S. parasanguis
genomic DNA was isolated with a Puregene DNA isolation kit (Gentra
Systems, Inc., Minneapolis, Minn.). Phage DNA was isolated as described
previously (40) or with a Qiagen lambda DNA isolation kit.
DNA probes used in Southern or plaque hybridization analyses were
radiolabeled with [
-32P]dCTP by nick translation with
a commercially available kit (Gibco BRL, Grand Island, N.Y.). Southern
and plaque hybridizations were performed as suggested by the membrane
manufacturer (Amersham Corp., Arlington Heights, Ill.) and included
high-stringency washes.
EMBL3 has been described previously (56). The library was
transfected into E. coli LE392, and recombinant phage
carrying fimA and sequences 5' to the fimA operon
were identified by plaque hybridization analysis (40).
pVT573 served as an initial hybridization probe to isolate a
recombinant phage carrying fimA and sequences 5' to the
fimA operon. Subsequently, pVT1198 was used as a probe to
obtain a recombinant phage carrying the entire pepO gene and sequences downstream from it.
RNA extraction and Northern hybridization analysis.
S.
parasanguis cells were harvested from 10-ml TH broth cultures
during mid-logarithmic-phase growth, and the cell pellet was
resuspended in water to 200 µl. RNA was isolated from cells with the
FastRNA BLUE protocol and a FastPrep instrument according to the
manufacturer's (Bio 101, Inc., Vista, Cal.) directions. Cells were
processed in the FastPrep instrument at a speed rating of 6 two times
for 30 s each time, for a total of 60 s. For Northern analysis, RNA (8 µg) was separated on a 1.2% agarose-0.44 M
formaldehyde gel, blotted, and hybridized to an
[
-32P]dCTP-labeled DNA probe as previously described
(25). A New England Biolabs (Beverly, Mass.) 0.46- to
4.06-kb RNA ladder was used as a molecular weight marker. The probe
used was a PCR-amplified 1,062-bp fragment from pepO (Fig.
1).
Electrotransformation of E. coli and S. parasanguis.
E. coli cells were prepared for electroporation
as previously described (4). Cells (50 µl) and
approximately 7 µg of DNA were electroporated in a 0.2-cm-gap-size
cuvette in a Bio-Rad Gene Pulser set at 2.5 kV, 25 µF, and 200
.
Immediately following electroporation, 360 µl of SOC medium
(40) was added to the cuvette. Cells were transferred to a
1.5-ml microcentrifuge tube and incubated at 37°C for 1 h. Cells
were then spread on Luria-Bertani agar plates supplemented with
appropriate antibiotics and incubated overnight at 37°C.
PCR. PCR was performed with a model 9600 thermocycler (Perkin-Elmer Cetus, Norwalk, Conn.) and a GeneAmp PCR reagent kit (Perkin-Elmer Cetus) according to the manufacturer's directions. Genomic DNAs of S. parasanguis FW213 and pepO allelic replacement mutant VT1346 were amplified with upstream (P1, 5'-TTCTCCCCACAAGACATTC-3') and downstream (P2A, 5'-GAGTTTGCTCCTTTAC-3') primers bracketing the pepO KpnI site. The PCR conditions were as follows: one cycle at 94°C for 3 min followed by 35 cycles of 1 min at 94°C, 1 min at 50°C, and 1 min at 72°C. The amplification reaction was completed with an additional cycle of 3 min at 72°C. The PCR amplification products were analyzed by agarose gel electrophoresis.
DNA sequencing and analysis. DNA sequencing was carried out at the Vermont Cancer Center DNA Analysis Facility at the University of Vermont. Nucleotide and protein similarity searches were done with the BLAST programs (1, 2) via the National Center for Biotechnology Information (NCBI) BLAST server (2). Protein similarity searches were conducted with both the NCBI nonredundant protein sequence database and the NCBI database of unfinished genomes. Pairwise and multiple amino acid sequence alignments were obtained with the BLAST and CLUSTAL W (48) programs, respectively, both with the default parameters.
Assay for endopeptidase activity. Endopeptidase activity was assayed by a procedure modified from that of Tan et al. (47). S. parasanguis strains were harvested from 500-ml TH broth cultures during late logarithmic growth, washed once with 40 ml of 20 mM potassium phosphate buffer (pH 6.0), and resuspended in 5 ml of cold 20 mM potassium phosphate buffer (pH 6.0). Cells were disrupted with a French press (Aminco, Silver Spring, Md.), with the pressure being maintained at 15,000 lb/in2. Extracts were obtained from disrupted cells by centrifugation at 17,210 × g for 20 min at 4°C. The protein concentration in each cell extract was determined with the bicinchoninic acid protein assay reagent (Pierce, Rockford, Ill.). Reaction mixtures contained 1.25 mM metenkephalin (Tyr-Gly-Gly-Phe-Met; Sigma Chemical Co., St. Louis, Mo.) in 20 mM Tris-HCl at pH 7.0 and 15 µg of cell extract in a total volume of 50 µl. Reaction mixtures were incubated at 30°C, and reactions were stopped by adding 10 µl of 30% acetic acid and cooling the mixtures to 4°C.
Hydrolysis of metenkephalin was detected by thin-layer chromatography (TLC). Samples were centrifuged in a microcentrifuge at 14,000 × g for 10 min at 4°C before 10 µl was spotted onto a precoated 0.25-cm-thick silica gel 60 plate (E. Merck AG, Darmstadt, Germany). TLC was performed with n-butanol-acetic acid-water (4:1:1 [vol/vol/vol]) as the mobile phase. Ten-microliter samples of 1.25 mM stock solutions of L-glycine, L-phenylalanine, L-methionine, L-tyrosine, and the tripeptide Try-Gly-Gly (Sigma) were spotted onto plates as markers. Silica gels were stained by being sprayed with 0.05% fluorescamine in 99% acetone (Sigma). Amino acids and peptides were visualized in UV light.Adhesion of S. parasanguis to SHA. Preparation of hydroxyapatite beads, clarification of saliva, preparation of SHA beads, and the adhesion assay used have been described previously (15). Data were obtained from two independent one-point adhesion assays (22) performed in triplicate.
Phylogenetic analysis.
Numerous S. parasanguis
PepO amino acid sequence homologues were identified from the BLAST
search and analyzed. Several hypothetical nematode proteins and the
KELL blood group glycoprotein were not included in the final analysis
(see Fig. 6). Inclusion of the nematode and KELL sequences in the
analysis did not change the results, but the topologies of the
resulting trees were otherwise uncertain. The final data set used to
construct phylogenetic trees consisted of the 22 amino acid sequences
listed in Table 2.
|
Nucleotide sequence accession number. The sequence data for pepO have been submitted to the DDBJ, EMBL, and GenBank databases under accession no. AF029677.
| |
RESULTS |
|---|
|
|
|---|
Isolation and characterization of the S. parasanguis
pepO gene.
The operon encoding the S. parasanguis
FW213 fimbria-associated adhesin, fimA, was cloned and
sequenced previously (18, 19). Initially, pVT573, containing
an internal fragment of fimA (Fig. 1), was used to screen a
genomic S. parasanguis phage
EMBL3 library for additional
sequences linked to the fimA operon. A recombinant phage
containing fimA and an incomplete upstream ORF was
identified. Subsequently, both pVT573 and a 1.9-kb EcoRI
fragment upstream of fimA (Fig. 1) were used to screen the
EMBL3 library again. Of approximately 3,000 plaques screened, 8 that
hybridized to both probes were isolated. DNA was prepared from three of
the recombinant phage, and restriction enzyme analysis revealed that all three harbored identical inserts. One phage, termed VT1331, was
chosen for further investigation. Phage VT1331 contained an insert of
approximately 11.0 kb, and Southern hybridization analysis confirmed
that the insert contained fimA on a 6.0-kb EcoRI
restriction fragment. A restriction site map of the 11.0-kb insert
revealed a 1.9-kb EcoRI fragment adjacent to the 6.0-kb
EcoRI fragment (Fig. 1). Subsequently, this 1.9-kb
EcoRI fragment, as well as an overlapping 4.4-kb
SalI-KpnI fragment, was subcloned from phage VT1331, and the nucleotide sequence of 2.3 kb of DNA was determined.
The product of the ORF upstream of the fimA operon displays homology to bacterial and eukaryotic zinc metallopeptidases. Nucleotide sequence analysis of the 2.3-kb region revealed the presence of a single ORF 148 bp upstream and divergently transcribed from the fimA operon (Fig. 1). The ORF was comprised of 1,893 nucleotides and was predicted to encode a protein of 631 amino acids and with a molecular mass of approximately 70.6 kDa. No typical signal sequence or regions of hydrophobicity were found in the predicted protein, suggesting that it is a soluble cytoplasmically located protein.
A search of current databases revealed that the predicted protein had significant amino acid sequence homology to a number of bacterial and eukaryotic proteins (Table 2). The highest sequence identity was with hypothetical proteins from Streptococcus pyogenes and Streptococcus pneumoniae and a partial sequence from Streptococcus gordonii (GenBank accession no. L11577) (31). High sequence similarity was also seen with the PepO endopeptidases of Lactococcus lactis (34, 53) (Fig. 2) and Lactobacillus helveticus (10). The FW213 ORF was designated pepO because of the high similarity between its predicted protein product and this latter group of bacterial endopeptidases.
|
125 and
39 (with respect to the translational start site), respectively. Within the
putative promoter regions was a 32-bp operator-like region consisting
of an imperfect repeat with a twofold axis of symmetry. A region with
features characteristic of bacterial rho-independent transcriptional terminators was found 42 bp downstream from the TAA
translational termination codon of pepO. This region
consisted of a 38-bp imperfect repeat with dyad symmetry followed by a
run of five A's. No other ORF of greater than 90 nucleotides was found within 300 bp downstream of the termination codon.
pepO is transcribed as a monocistronic message. Based on DNA sequence analysis, it was reasonable to predict that pepO was transcribed as a monocistronic message. Northern hybridization analysis was performed to verify this assumption. A 1,062-bp PCR product (Fig. 1) corresponding to an internal coding region of pepO was hybridized to total RNA from S. parasanguis FW213 that had been grown in TH broth. Under high-stringency conditions, the probe hybridized to an abundant RNA transcript with an apparent molecular size of approximately 2.1 kb (Fig. 3). A transcript of this size is consistent with the hypothesis that pepO is transcribed as a monocistronic mRNA. The pepO probe also hybridized to a second, slightly larger and less abundant transcript that is obscured in reproductions of autoradiographs because of its close proximity to the major band. At present, the physiological significance of these two transcripts is unknown.
|
Construction of an S. parasanguis pepO mutant strain. A disrupted allele of pepO was constructed by inserting aphA-3 (50), a gene for kanamycin resistance (Kmr), into the KpnI restriction site of pepO (Fig. 1). The mutated allele was cloned into a plasmid unable to replicate in streptococcal cells, and the chromosomal mutation was obtained by the method of allelic replacement (19). The supercoiled plasmid pVT1333, carrying the disrupted pepO gene, was transformed into FW213 by electroporation. Transformants arising by allelic replacement were expected to be Kmr and tetracycline sensitive (Tcs). Therefore, transformants were initially selected for Kmr and then screened for Tcs. Ten transformants with the expected allelic replacement phenotype were screened by Southern hybridization analysis. The DNA from 9 of 10 transformants gave hybridization patterns indicative of allelic replacement (Fig. 4A). The pepO probe hybridized with both 6.0- and 1.9-kb EcoRI restriction fragments in the wild-type strain (Fig. 4A, lane 1). The 1.9-kb fragment was absent in the putative pepO mutants and replaced by a 3.4-kb fragment (Fig. 4A, lanes 2 and 3). The Southern blot was then stripped and probed with the Kmr determinant aphA-3 (Fig. 4B). The aphA-3 probe hybridized with the new 3.4-kb fragment in the pepO mutants (Fig. 4B, lanes 2 and 3) but not with fragments in the wild-type strain (lane 1). These data confirm that the shift in size of the fragment from 1.9 to 3.4 kb was due to insertion of the Kmr gene into pepO. Proper replacement of the wild-type pepO allele with the mutagenized allele was also confirmed by PCR analysis (data not shown). One pepO mutant, designated VT1346, was chosen for further study.
|
The pepO mutant adheres to SHA. It is unlikely that PepO acts directly as an adhesin in S. parasanguis FW213, but because of the close linkage of pepO to the operon encoding the fimbria-associated adhesin, fimA, we examined whether PepO plays a role in adhesion. No difference was found between wild-type and mutant strains in an SHA adhesion assay (data not shown), indicating that the inactivation of pepO did not affect the ability of S. parasanguis cells to adhere to SHA. We also found no obvious differences in growth rate or viability between wild-type and pepO mutant cells under standard growth conditions (data not shown).
FW213 PepO has activity similar to that of mammalian NEP. In the human brain, NEP is a major inactivator of endogenous opioid peptides, the enkephalins (38). NEP cleaves substrates at the amino side of hydrophobic amino acids, such as phenylalanine; in the case of the enkephalins, it cleaves at Gly3-Phe4. Based on the similarity between S. parasanguis PepO and mammalian NEP, we reasoned that S. parasanguis FW213 would hydrolyze physiological substrates of NEP but that the pepO mutant strain VT1346 would not. Endopeptidase activities of wild-type and pepO mutant strains were compared (Fig. 5) with an in vitro assay that included the substrate metenkephalin (Tyr-Gly-Gly-Phe-Met). Endopeptidase activity was detected in protein extracts from the wild-type strain but not from the pepO mutant strain. Wild-type cell extracts cleaved metenkephalin at the Gly3-Phe4 peptide bond, producing the products Tyr-Gly-Gly and Phe-Met (Fig. 5A). These products were not detected when extracts of the pepO mutant strain were incubated with the substrate (Fig. 5B). These data indicate that S. parasanguis FW213 pepO encodes an enzyme with activity similar to those of known mammalian endopeptidases.
|
Phylogenetic analysis of PepO and its homologues. Phylogenetic analysis was included in this study because of the striking similarity between bacterial PepO sequences and their eukaryotic homologues. The S. parasanguis PepO sequence and 7 bacterial and 14 eukaryotic sequences (Table 2) were aligned and then analyzed by distance methods and by maximum parsimony. A phylogenetic tree (Fig. 6) was constructed from the multiple sequence alignment. Similar results were obtained with different methods of tree construction and with a variety of sequence sets (see Materials and Methods). A clear distinction between eukaryotic and prokaryotic species was seen in 100% of the bootstrap replicates, suggesting that the PepO homologues fall into two monophyletic groups. Within the bacterial branch of the tree, the phylogeny shown was generally consistent with the taxonomic classification given by the NCBI taxonomy browser (47a). What was exceptional about the phylogeny is that PepO homologues were not detected in completely sequenced genomes of organisms representing a broad range of taxa. These included archaea, fungi, early branching bacteria (Aquificales), proteobacteria, spirochetes, cyanobacteria, chlamydia, mycoplasmas, and Bacillus subtilis. These results suggested lateral gene transfer of pepO sequences between bacteria and eukaryotes.
|
| |
DISCUSSION |
|---|
|
|
|---|
The purpose of this study was to determine if any factors immediately upstream of the fimA operon were associated with adherence or survival within the host. Just 148 bp upstream and divergently transcribed from the fimA operon, a 1,893-bp ORF (pepO) that encodes a protein with many structural features in common with the M13 (neprilysin) family of metallopeptidases was identified. This family of metallopeptidases includes bacterial members as well as mammalian neuropeptide-processing, immunoregulatory, and peptide hormone-processing zinc metallopeptidases (36). While the role of the bacterial enzymes is uncertain, the mammalian enzymes have been shown to play essential roles in events such as inflammatory response phenomena and in pain and cardiovascular regulation (45, 51, 52).
FW213 PepO contains the essential HEXXH consensus motif typical of this family of peptidases as well as numerous positionally conserved residues known to be critical for the activity of the mammalian enzymes. Some of the most important residues in the active sites of NEP and ECE are included in the HEXXH consensus motif. In mammalian NEP, the two histidines (His583 and His587) are zinc-coordinating residues, and the glutamate (Glu584) plays an important role in catalysis (38, 44). In PepO, each of these important residues as well as many other residues surrounding the critical HEXXH consensus motif are positionally conserved (Fig. 2). In addition to the conserved HEXXH motif, FW213 PepO contains other positionally conserved residues known by site-directed mutagenesis to be important in zinc binding, substrate binding, or hydrolytic activity in NEP (Fig. 2). These include (in NEP) an asparagine (Asn542), an alanine (Ala543), and a valine (Val580) that are involved in substrate binding; a third Zn-coordinating ligand (Glu646); an aspartic acid that is critical for hydrolytic activity (Asp650); and a histidine (His711) that may be involved in transition state binding (14, 30, 38, 55).
pepO appears to be transcribed as a monocistronic message. One major transcript and one minor transcript, differing in size by about 200 bases, were consistently detected by Northern hybridization. The 2.1-kb major transcript is within the size range expected from the ORF that is predicted by the pepO sequence; the minor transcript is slightly larger. It is possible that these two transcripts are the result of multiple transcription initiation sites or differential RNA processing. The physiological relationship between the two transcripts in S. parasanguis is currently unknown. Three distinct NEP mRNAs that differ only in their 5' noncoding regions have been identified for humans and rats, and data suggest that their expression is regulated developmentally and in a tissue-specific manner (31, 38). The expression of S. parasanguis pepO may also be regulated, and we suggest that this regulation may be related to the expression of the fimA operon. The tight physical arrangement of pepO and the fimA operon, as well as the overlapping arrangement of their 5' regulatory regions, suggests the possible cotranscription of these genes. Further analysis is necessary to determine if specific sequences within the 148-bp region separating pepO and the fimA operon are involved in their coregulation.
An investigation of the physiological role of PepO in S. parasanguis was initiated by constructing a mutant strain of FW213. Initially, the adhesion and growth properties of the mutant were examined. PepO does not appear to play a role in the adhesion of S. parasanguis cells in an in vitro SHA tooth surface model. This finding is not surprising, since it is known that FimA is not required for binding to SHA (17). An important, but as-yet-unanswered question, is whether PepO plays a role in S. parasanguis endocarditis, as does FimA (6). In this regard, it is of interest that a putative zinc metallopeptidase, MEP1, which has homology to the M13 family of metallopeptidases (including mammalian NEP and now S. parasanguis PepO), has been identified for the highly pathogenic blood-feeding nematode Haemonchus contortus (37). H. contortus infects the fourth division of the stomach of sheep, goats, and other small ruminants and can induce anemia, weight loss and, in severe cases, death of the animal. The putative zinc metallopeptidase MEP1 is developmentally regulated, with expression being limited to the blood-feeding stages of H. contortus. Whereas we found that the disruption of pepO did not affect the growth characteristics of FW213 in TH broth under standard conditions, we observed recently that wild-type S. parasanguis FW213 forms larger colonies on blood agar plates than the pepO mutant. S. parasanguis PepO may also play a role during growth in the presence of blood, such as when streptococcal cells gain access to the bloodstream.
Within the M13 family of metallopeptidases, NEP is the prototype and the most thoroughly characterized. The biochemical activity of PepO was examined by testing the ability of wild-type and mutant strains to hydrolyze metenkephalin, a physiological substrate of mammalian NEP. Wild-type cell extracts cleaved metenkephalin at the same site as does NEP, producing the products Tyr-Gly-Gly and Phe-Met. Cell extracts from the pepO mutant failed to cleave metenkephalin at the Gly3-Phe4 peptide bond. These data indicate that the pepO gene in S. parasanguis FW213 encodes an enzyme with activity similar to that of NEP. Furthermore, these data emphasize the close correspondence between the active sites of S. parasanguis PepO and mammalian NEP. The similarity of PepO to NEP, in terms of conservation of critical amino acid residues and substrate specificity, demonstrates that PepO is a member of the M13 family of metallopeptidases.
Homologues of the PepO endopeptidase occur in many animals but in only
a limited group of bacteria, the majority of which are gram positive
and pathogenic for humans. We wonder about the origin of this
endopeptidase in these diverse organisms. Since the phylogenetic trees
constructed in this study are consistent with species trees, it is
possible that the ultimate ancestor of PepO and its animal homologues
was present in an organism that gave rise to both modern bacteria and
eukaryotes. However, PepO sequence homologues were not detected by the
BLAST search of completely sequenced genomes representing a broad range
of taxa, including those from groups that diverged early. While this
finding could be explained by postulating the widespread loss of PepO
sequences from this broad range of taxa, it is highly unlikely. A more
plausible explanation is that PepO sequences were acquired through
horizontal genetic exchange between bacteria and eukaryotes. Given the
distribution of PepO homologues that we found, this event probably took
place after the divergence of the eubacterial, archaeal, and eukaryotic lineages. Rawlings and Barrett (36) have proposed that the
genes for a number of bacterial metallopeptidases were transferred into eukaryotic cells by endosymbiotic organisms that gave rise to organelles. Transfer of PepO probably did not occur by this mechanism, given that PepO sequences have not been found in proteobacteria and
recent data indicating that the
-proteobacterium Rickettsia prowazekii and mitochondria are specific evolutionary relatives (3). Whereas the direction of genetic transfer cannot be
determined from the information currently available, it is clear from
the comparison of PepO homologues that the protein, particularly in the
region encompassing the active site, is under strong evolutionary constraints.
The PepO homologues play critical roles in eukaryotic physiology, and it is likely that PepO plays an important role in the relatively small group of bacteria that have maintained or acquired similar sequences. Future studies are aimed at elucidating the physiological role of PepO in S. parasanguis. PepO may be useful as a model for understanding the regulation of this family of enzymes.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by Public Health Service grant R37-DE11000 from the National Institutes of Health. Phylogenetic analysis was performed at the Molecular Modeling Facility of the Vermont Cancer Center, which is supported by the National Cancer Institute and the Lake Champlain Cancer Research Organization.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: University of Vermont, Department of Microbiology and Molecular Genetics, Stafford Hall, Burlington, VT 05405. Phone: (802) 656-1121. Fax: (802) 656-8749. E-mail: pfivesta{at}zoo.uvm.edu.
Editor: J. R. McGhee
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and J. D. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410[Medline]. |
| 2. |
Altschul, S. F.,
T. L. Maddem,
A. A. Schaffer,
J. Zhang,
Z. Zhang,
W. Miller, and J. D. Lipman.
1997.
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.
Nucleic Acids Res.
25:3389-3402 |
| 3. | Andersson, S. G. E., A. Zomorodipour, J. O. Andersson, T. Sicheritz-Ponten, U. C. M. Alsmark, R. M. Podowski, A. K. Naslund, A.-S. Eriksson, H. H. Winkler, and C. G. Kurland. 1998. The genome sequence of Rickettsia prowazekii and the origin of mitochondria. Nature 396:133-140[Medline]. |
| 4. | Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. A. Smith, J. G. Seidman, and K. Struhl (ed.). 1989. Current protocols in molecular biology. John Wiley & Sons, Inc., New York, N.Y. |
| 5. |
Baddour, L. M.
1994.
Virulence factors among gram-positive bacteria in experimental endocarditis.
Infect. Immun.
62:2143-2148 |
| 6. | Burnette-Curley, D., V. Wells, H. Viscount, C. L. Munro, J. C. Fenno, P. Fives-Taylor, and F. L. Macrina. 1995. FimA, a major virulence factor associated with Streptococcus parasanguis endocarditis. Infect. Immun. 63:4669-4674[Abstract]. |
| 7. | Carlsson, J., M. Grahnen, G. Johnson, and S. Wikner. 1970. Establishment of Streptococcus sanguis in the mouths of infants. Arch. Oral Biol. 15:1143-1148[Medline]. |
| 8. |
Cha, M.-K.,
H.-K. Kim, and I.-H. Kim.
1996.
Mutation and mutagenesis of the thiol peroxidase of Escherichia coli and a new type of thiol peroxidase family.
J. Bacteriol.
178:5610-5614 |
| 9. | Chen, C., G. Salles, M. F. Seldin, A. E. Kister, E. L. Reinherz, and M. A. Shipp. 1992. Murine common acute lymphoblastic leukemia antigen (CD10 neutral endopeptidase 24.11): molecular characterization, chromosomal localization, and modeling of the active site. J. Immunol. 148:2817-2825[Abstract]. |
| 10. |
Chen, Y.-S., and J. L. Steele.
1998.
Genetic characterization and physiological role of endopeptidase O from Lactobacillus helveticus CNRZ32.
Appl. Environ. Microbiol.
64:3411-3415 |
| 11. | Cole, R. M., G. B. Calandra, E. Huff, and K. M. Nugent. 1976. Attributes of potential utility in differentiating among `group H' streptococci or Streptococcus sanguis. J. Dent. Res. 55:A142-153. |
| 12. | Devault, A., C. Lazure, C. Nault, H. Le Moual, N. G. Seidah, M. Chretien, P. Kahn, J. Powell, J. Mallet, A. Beaumont, B. P. Roques, P. Crine, and C. Boileau. 1987. Amino acid sequence of rabbit kidney neutral endopeptidase 24.11 (enkephalinase) deduced from a complementary DNA. EMBO J. 6:1317-1322[Medline]. |
| 13. | Dintilhac, A., and J.-P. Claverys. 1997. The adc locus, which affects competence for genetic transformation in Streptococcus pneumoniae, encodes an ABC transporter with a putative lipoprotein homologous to a family of streptococcal adhesins. Res. Microbiol. 148:119-131[Medline]. |
| 14. | Dion, N., H. Le Moual, M.-C. Fournie-Zaluski, B. P. Roques, P. Crine, and G. Boileau. 1995. Evidence that Asn542 of neprilysin (EC 4.3.24.11) is involved in binding of the P2' residue of substrates and inhibitors. Biochem. J. 311:623-627. |
| 15. |
Fachon-Kalweit, S.,
B. L. Elder, and P. Fives-Taylor.
1985.
Antibodies that bind to fimbriae block adhesion of Streptococcus sanguis to saliva-coated hydroxyapatite.
Infect. Immun.
48:617-624 |
| 16. | Felsenstein, J. 1995. PHYLIP (Phylogeny Inference Package) version 3.5c. Department of Genetics, University of Washington, Seattle. |
| 17. | Fenno, J. C. 1993. Genetic analysis of a chromosomal locus of Streptococcus parasanguis encoding a fimbrial adhesin and membrane transport system. Ph.D. thesis. University of Vermont, Burlington. |
| 18. |
Fenno, J. C.,
D. LeBlanc, and P. Fives-Taylor.
1989.
Nucleotide sequence analysis of a type 1 fimbrial gene of Streptococcus sanguis FW213.
Infect. Immun.
57:3527-3533 |
| 19. | Fenno, J. C., A. Shaikh, and P. Fives-Taylor. 1993. Characterization of allelic replacement in Streptococcus parasanguis: transformation and homologous recombination in a `nontransformable' streptococcus. Gene 130:81-90[Medline]. |
| 20. | Fenno, J. C., A. Shaikh, G. Spatafora, and P. Fives-Taylor. 1995. The fimA locus of Streptococcus parasanguis encodes an ATP-binding membrane transport system. Mol. Microbiol. 15:849-863[Medline]. |
| 21. |
Fives-Taylor, P. M.
1982.
Isolation and characterization of a Streptococcus sanguis FW213 mutant non-adherent to saliva-coated hydroxyapatite beads, p. 206-209.
In
D. Schlessinger (ed.), Microbiology 1982. American Society for Microbiology, Washington, D.C.
|
| 22. |
Fives-Taylor, P. M., and D. W. Thompson.
1985.
Surface properties of Streptococcus sanguis FW213 mutants nonadherent to saliva-coated hydroxyapatite.
Infect. Immun.
47:752-759 |
| 23. |
Fives-Taylor, P. M.,
F. L. Macrina,
T. J. Pritchard, and S. J. Peene.
1987.
Expression of Streptococcus sanguis antigens in Escherichia coli: cloning of a structural gene for adhesion fimbriae.
Infect. Immun.
55:123-128 |
| 24. | Frandsen, E. V. G., V. Pedrazzoli, and M. Kilian. 1991. Ecology of viridans streptococci in the oral cavity and pharynx. Oral Microbiol. Immunol. 6:129-133[Medline]. |
| 25. | Froeliger, E. H., and P. Fives-Taylor. 1998. Analysis of adherence-associated gene expression in Streptococcus parasanguis: a method for RNA isolation. Methods Cell Sci. 20:143-151. |
| 26. |
Hase, C. C., and R. A. Finkelstein.
1993.
Bacterial extracellular zinc-containing metalloproteases.
Microbiol. Rev.
57:823-837 |
| 27. | Jenkinson, H. F. 1995. Genetic analysis of adherence by oral streptococci. J. Ind. Microbiol. 15:186-192[Medline]. |
| 28. |
Jenkinson, H. F., and R. J. Lamont.
1997.
Streptococcal adhesion and colonization.
Crit. Rev. Oral Biol. Med.
8:175-200 |
| 29. |
Kolenbrander, P. E.,
R. N. Andersen, and N. Ganeshkumar.
1994.
Nucleotide sequence of the Streptococcus gordonii PK488 coaggregation adhesin gene, scaA, and ATP-binding cassette.
Infect. Immun.
62:4469-4480 |
| 30. | Le Moual, H., N. Dion, B. P. Roques, P. Crine, and G. Boileau. 1994. Asp650 is crucial for catalytic activity of neutral endopeptidase 24-11. Eur. J. Biochem. 221:475-480[Medline]. |
| 31. |
Li, C.,
R. M. Booze, and L. B. Hersh.
1995.
Tissue-specific expression of rat neutral endopeptidase (neprilysin) mRNAs.
J. Biol. Chem.
270:5723-5728 |
| 32. | Malfroy, B., J. W. Kuang, P. H. Seeburg, A. J. Mason, and P. R. Schofield. 1988. Molecular cloning and amino acid sequence of human enkephalinase (neutral endopeptidase). FEBS Lett. 229:206-210[Medline]. |
| 33. | Malfroy, B., P. R. Schofield, W. J. Kuang, P. H. Seeburg, A. J. Mason, and W. J. Henzel. 1987. Molecular cloning and amino acid sequence of rat enkephalinase. Biochem. Biophys. Res. Commun. 144:59-66[Medline]. |
| 34. |
Mierau, I.,
P. S. T. Tan,
A. J. Haandrikman,
J. Kok,
K. J. Leenhouts,
W. N. Konings, and G. Venema.
1993.
Cloning and sequencing of the gene for a lactococcal endopeptidase, an enzyme with sequence similarity to mammalian enkephalinase.
J. Bacteriol.
175:2087-2096 |
| 35. | Nyvad, B., and M. Kilian. 1987. Microbiology of the early colonization of human enamel and root surfaces. Scand. J. Dent. Res. 95:369-380[Medline]. |
| 36. | Rawlings, N. D., and A. J. Barrett. 1995. Evolutionary families of metallopeptidases. Methods Enzymol. 248:183-228[Medline]. |
| 37. | Redmond, D. L., D. P. Knox, G. Newlands, and W. D. Smith. 1997. Molecular cloning and characterization of a developmentally regulated putative metallopeptidase present in a host protective extract of Haemonchus contortus. Mol. Biochem. Parasitol. 85:77-87[Medline]. |
| 38. | Roques, B. P., F. Noble, V. Dauge, M.-C. Fournie-Zaluski, and A. Beaumont. 1993. Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology. Pharmacol. Rev. 45:87-146[Medline]. |
| 39. | Saitou, N., and M. Nei. 1987. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4:406-425[Abstract]. |
| 40. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 41. | Schmidt, M., B. Kroger, E. Jacob, H. Seulberger, T. Subkowski, R. Otter, T. Meyer, G. Schmalzing, and H. Hillen. 1994. Molecular characterization of human and bovine endothelin converting enzyme (ECE-1). FEBS Lett. 356:238-243[Medline]. |
| 42. | Shima, H., M. Yamanouchi, K. Omori, M. Sugiura, K. Kawashima, and T. Sato. 1995. Endothelin-1 production and endothelin converting enzyme expression by guinea pig airway epithelial cells. Biochem. Mol. Biol. Int. 37:1001-1010[Medline]. |
| 43. |
Shimada, K.,
M. Takahashi, and K. Tanzawa.
1994.
Cloning and functional expression of endothelin-converting enzyme from rat endothelial cells.
J. Biol. Chem.
269:18275-18278 |
| 44. | Shimada, K., M. Takahashi, A. J. Turner, and K. Tanzawa. 1996. Rat endothelin converting enzyme-1 forms a dimer through Cys412 with a similar catalytic mechanism and a distinct substrate binding mechanism compared with neutral endopeptidase-24.11. Biochem. J. 315:863-867. |
| 45. |
Shipp, M. A.,
G. B. Stefano,
S. N. Switzer,
J. D. Griffin, and E. L. Reinherz.
1991.
CD10 (CALLA) neutral endopeptidase 24.11 modulates inflammatory peptide-induced changes in neutrophil morphology, migration, and adhesin proteins and is itself regulated by neutrophil activation.
Blood
78:1834-1841 |
| 46. | Swofford, D. L. 1997. PAUP (protein alignment using parsimony). Smithsonian Institute, Washington, D.C. |
| 47. |
Tan, P. S. T.,
K. M. Pos, and W. N. Konings.
1991.
Purification and characterization of an endopeptidase from Lactococcus lactis subsp. cremoris Wg2.
Appl. Environ. Microbiol.
57:3593-3599 |
| 47a. | The taxonomy browser. 6 December 1995. [Online.] D. Leipe and V. Soussou. http://www.ncbi.nlm.nih.gov/Taxonomy. [4 March 1999, last date accessed.] |
| 48. |
Thompson, J. D.,
D. G. Higgins, and T. J. Gibson.
1994.
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.
Nucleic Acids Res.
22:4673-4680 |
| 49. |
Tobian, J. A.,
M. L. Cline, and F. L. Macrina.
1984.
Characterization and expression of a cloned tetracycline-resistant determinant from the chromosome of Streptococcus mutans.
J. Bacteriol.
160:556-563 |
| 50. | Trieu-Cuot, P., and P. Courvalin. 1983. Nucleotide sequence of the Streptococcus faecalis plasmid gene encoding the 3'5'-aminoglycoside phosphotransferase type III. Gene 23:331-341[Medline]. |
| 51. | Turner, A. J., and L. J. Murphy. 1996. Molecular pharmacology of endothelin converting enzymes. Biochem. Pharmacol. 51:91-102[Medline]. |
| 52. | Turner, A. J., and K. Tanzawa. 1997. Mammalian membrane metallopeptidases: NEP, ECE, Kell, and PEX. FASEB J. 11:355-364[Abstract]. |
| 53. |
Tynkkynen, S.,
G. Buist,
E. Kunji,
J. Kok,
B. Poolman,
G. Venema, and A. Haandrikman.
1993.
Genetic and biochemical characterization of the oligopeptide transport system of Lactococcus lactis.
J. Bacteriol.
175:7523-7532 |
| 54. | Van Hoeven, N., G. Spatafora, and P. Fives-Taylor. 1998. Identification of a putative antioxidant in Streptococcus parasanguis. J. Dent. Res. 77:1214. (Abstract.) |
| 55. | Vijayaraghavan, J., Y.-A. Kim, D. Jackson, M. Orlowski, and L. B. Hersh. 1990. Use of site-directed mutagenesis to identify valine-573 in the S'1 binding site of rat neutral endopeptidase 24.11 (enkephalinase). Biochemistry 29:8052-8056[Medline]. |
| 56. | Wu, H., K. P. Mintz, M. Ladha, and P. M. Fives-Taylor. 1998. Isolation and characterization of Fap1, a fimbriae-associated adhesin of Streptococcus parasanguis FW213. Mol. Microbiol. 28:487-500[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|